Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Immunoglobulin M Concentration in Waldenström Macroglobulinemia: Correlation With Bone Marrow B Cells and Plasma Cells
Clinical lymphoma, myeloma and leukemia, 2013-04, Vol.13 (2), p.211-213
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
P-390 The differentiation and expansion of T cell clonotypes in the bone marrow following ASCT: insights from the Phase 2 CARDAMON study
Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S255-S256
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Minimal residual disease (MRD) in Waldenström macroglobulinaemia (WM): Impact on survival outcomes with rituximab-based therapies
Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e310-e311
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
OAB-012: Depth of response and MRD in newly diagnosed ultra high-risk myeloma and plasma cell leukemia treated with Dara-CVRd and V-MEL ASCT: results of the molecularly stratified UK OPTIMUM/MUKnine trial
Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21, p.S8-S8
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk
Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21, p.S10-S10
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
OAB-018: From CARDAMON to CoMMpass: a mutational signature that predicts carfilzomib-specific outcomes in myeloma
Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S11-S12
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
P-084: Bone marrow of patients post ASCT, but not chemotherapy consolidation, contains expanded T cell receptor clonotypes that are present at diagnosis: results from the Phase 2 CARDAMON study
Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S81-S82
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
P-228: ASCT does not benefit patients who are MRD negative following induction therapy: updated results from the Phase 2 Cardamon study
Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S160-S161
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
OAB-003: CARDAMON:Carfilzomib (K) maintenance following Autologous Stem Cell Transplant (ASCT) or carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation for newly diagnosed (NDTE) multiple myeloma (MM)
Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21, p.S2-S3
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Sequential minimal residual disease (MRD) monitoring: Results from the UK Myeloma XI trial
Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e45-e46
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Outcomes of newly diagnosed multiple myeloma with deferred ASCT after achieving ≥VGPR following PAD induction in the Phase 2 PADIMAC study
Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e288-e289
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
3.14 The Influence of Genetic Background and Infectious Exposure on the Development of Chronic Lymphocytic Leukaemia and Other B-Cell Malignancies: Evidence from High-Sensitivity Screening in Leeds and Rural Uganda
Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S205-S206
2011
Volltextzugriff (PDF)
1 – 12 von 12
Suche als RSS-Feed
Aktive Filter
Zeitschrift / SerieClinical Lymphoma, Myeloma And Leukemia
Suchergebnisse filtern
Filter anzeigen